Compositions for the transdermal and dermal administration of biologically active agents
EP0795329A1
Parenterally injectable piroxicam solutions
ITRM930732D0
Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration
ITRM930687D0
Oral delayed- and controlled-release pharmaceutical preparations based on isorbide nitrates with which it is possible to use only one daily administration
ES2048640A1
A method for the preparation of cetiltrimetilamonio naproxenato.
GR910100519A
A method for the preparation of cetyltrimethylammonium naproxenate
PT99928A
Process for preparing nitroxenate of cetil-trimethylamonyl
Melatonin derivative having therapeutic activity in dermatology
AU8548291A
Menthol derivative having spasmolytic activity
AU8183491A
Compounds having cognition enhancer activity, a process for the preparation thereof and pharmaceutical compositions containing them
ITMI911468D0
Anti-inflammatory and anti-atherosclerotic salicylate derivative with prolonged action
AU7586191A
Hydroxyproline derivative, a process for the preparation thereof and pharmaceutical compositions containing it
ITMI910842A1
Compound with calcium antagonistic activity
IT9048325D0
Use of tromethamine salts in calcitonin-based pharmaceutical compositions that can be administered by the nasal route in human therapeutic medicine.
IT9048063D0
Calcitonin-based pharmaceutical compositions administrable by the nasal route
IT9048064D0
Calcitonin-based pharmaceutical compositions administrable by the nasal route in human therapy
IT9047939D0
Derivatives of antibiotic polyene macrolide, their salts and the pharmaceutical compounds that they make up
IT8948659D0
Topical use pharmaceutical preparation based on heparin, heparinoid and parts, LMW heparin and additional VLMW heparin liposome, with elevated absorption and controlled epidermis clearance.
